Orphazyme A Asset Turnover Ratio (ORPH), as of fourth quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Orphazyme A  (ORPH)
 

Orphazyme A Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Orphazyme A asset turnover ratio, the ability of Orphazyme A's assets to generate revenue in the fourth quarter 2021, increased sequentially to 0.06 in the fourth quarter (Dec 31 2021), ORPH's balance sheet remain strong.

Within sector 243 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2021 compared to the preceding quarter from 0 to 3990.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ORPH Asset Turnover Ratio (Dec 31 2021)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2020)
IV. Quarter
Y / Y Asset Change - - - - -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.06 - - - -
ORPH's Total Ranking # 3990 # 0 # 0 # 0 # 0
Seq. Asset Change -80.3 % 0 % 0 % - -
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 244
Healthcare Sector # 607
Overall Market # 3990

Asset Turnover Ratio Statistics
High Average Low
0.04 0.04 0.04
(Dec 31 2021)  




ORPH Company Profile • Back to ORPH Efficiency Comparisons • Compare ORPH Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2021 Assets at quarter ending Dec 31 2021
Nevro Corp   0.61 $ 386.905  Millions$ 633.047  Millions
Ortho Clinical Diagnostics Holdings Plc  0.61 $ 2,042.800  Millions$ 3,342.600  Millions
Surgalign Holdings Inc   0.61 $ 90.500  Millions$ 148.649  Millions
Vertex Pharmaceuticals Inc  0.60 $ 7,574.400  Millions$ 12,596.998  Millions
Alkermes Plc   0.60 $ 1,173.751  Millions$ 1,958.927  Millions
Exelixis Inc   0.60 $ 1,434.970  Millions$ 2,405.448  Millions
Organon and Co   0.59 $ 6,304.000  Millions$ 10,641.500  Millions
Eli Lilly And Company  0.59 $ 28,318.400  Millions$ 47,910.075  Millions
Hologic Inc  0.59 $ 5,138.900  Millions$ 8,709.900  Millions
Stereotaxis Inc   0.59 $ 35.021  Millions$ 59.765  Millions
Abbott Laboratories  0.58 $ 43,075.000  Millions$ 73,761.250  Millions
Natera Inc   0.58 $ 625.486  Millions$ 1,072.832  Millions
Nephros Inc   0.58 $ 10.404  Millions$ 17.849  Millions
Earth Science Tech Inc   0.58 $ 0.032  Millions$ 0.055  Millions
Collegium Pharmaceutical Inc   0.58 $ 403.119  Millions$ 698.420  Millions
Surmodics Inc   0.58 $ 105.842  Millions$ 183.438  Millions
Conmed Corporation  0.58 $ 1,010.635  Millions$ 1,757.174  Millions
Neurocrine Biosciences Inc   0.57 $ 1,133.500  Millions$ 1,973.150  Millions
Lannett Company Inc  0.57 $ 406.412  Millions$ 707.978  Millions
Lemaitre Vascular Inc   0.57 $ 154.424  Millions$ 269.037  Millions
Sangui Biotech International Inc  0.57 $ 0.076  Millions$ 0.132  Millions
Iqvia Holdings Inc   0.57 $ 13,874.000  Millions$ 24,281.500  Millions
Edap Tms Sa  0.57 $ 49.353  Millions$ 86.493  Millions
Biodesix Inc   0.57 $ 54.506  Millions$ 95.846  Millions
Societal Cdmo Inc   0.57 $ 75.360  Millions$ 132.521  Millions
Koru Medical Systems Inc   0.57 $ 23.490  Millions$ 41.406  Millions
Dynavax Technologies Corporation  0.57 $ 438.442  Millions$ 774.246  Millions
Amarin Corp Plcuk  0.56 $ 583.187  Millions$ 1,034.778  Millions
Ispecimen inc   0.56 $ 11.135  Millions$ 19.789  Millions
Insulet Corporation  0.56 $ 1,098.800  Millions$ 1,952.875  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.